The Royal Australian and New Zealand College of Ophthalmologists held its annual conference on Queensland’s Gold Coast in August, with expert speakers providing an update on the latest advances in medical and surgical retina.
Keynote speakers for the conference were Dr. Carmen Puliafito, from the Doheny Eye Institute at the University of Southern California; Dr. Sophie Bakri from the US Mayo Clinic; and Associate Professor Philip Polkinghorne, from the University of Auckland.
Several senior Queensland ophthalmologists also took to the platform, including Dr. David Hilford, Dr. Anthony Kwan, Dr. Les Manning, Dr. Rowan Porter and Dr. Nathan Walker.
Keynote speeches on the opening day of the conference focussed on optical coherence tomography (OCYT), and imaging related to both medical and surgical retina.
Conference delegates took advantage of the Gold Coast’s many tourist attractions, with social functions, including a golf day and the Eye Foundation Dinner
Dr. Bakri also updated the 250 delegates on recent trials comparing the anti-VEGF therapies Lucentis (ranibizumab) and Avastin (bevacizumab). She also discussed the pivotal trials that led to approval of Eylea by the US Food and Drug Administration.
Day Two highlights included lectures on current concepts in the evaluation and treatment of retinal venous occlusive disease and the management of macular oedema.
Conference delegates took advantage of the Gold Coast’s many tourist attractions, with social functions, including a golf day and the Eye Foundation Dinner, providing valuable opportunities to network.
